SCHEMBL3044274

SCHEMBL3044274

CCOC(=O)N1CCc2cc(C(=O)N(C)C)sc2CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
MAPT P10636 4/20 0.42
KDM4E B2RXH2 2/20 0.42
GAA P10253 2/20 0.42
HPGD P15428 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
MAPK1 P28482 2/20 0.40
HDAC6 Q9UBN7 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 2/20 0.39
NPC1 O15118 1/20 0.39
USP2 O75604 1/20 0.39
RAB9A P51151 1/20 0.39
CYP3A4 P08684 2/20 0.38
GRM5 P41594 2/20 0.38
CYP1A2 P05177 1/20 0.38
MCL1 Q07820 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11180673 0.86 ALDH1A1 (0.51) ALDH1A1MAPTKDM4EGAAHPGD
SCHEMBL11176901 0.86 KDM4E (0.48) ALDH1A1MAPTKDM4EGAAHPGD
SCHEMBL1181655 0.82 HDAC6 (0.47) ALDH1A1MAPTKDM4EGAAHPGD
SCHEMBL1181893 0.81 HDAC6 (0.45) ALDH1A1MAPTKDM4EGAAHPGD
SCHEMBL13560073 0.81 ALDH1A1 (0.43) ALDH1A1MAPTKDM4EGAAMAPK1
SCHEMBL1181044 0.80 HDAC6 (0.40) ALDH1A1MAPTKDM4EGAAHPGD
SCHEMBL2993002 0.79 GRM5 (0.41) ALDH1A1MAPTKDM4EGAAKMT2A
SCHEMBL984992 0.79 POLB (0.47) ALDH1A1MAPTKDM4EGAAMAPK1
SCHEMBL16038585 0.78 GRM5 (0.43) ALDH1A1MAPTKDM4EGAASMN1; SMN2
SCHEMBL976216 0.77 HDAC6 (0.55) ALDH1A1MAPTKDM4EGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778243-B1 SUBSTITUTED AZEPINE DERIVATIVES AS SEROTONIN RECEPTOR MODULATORS ATHERSYS INC (US) 2012-10-31 EP disclosed
US-7718647-B2 Substituted azepine derivatives as serotonin receptor modulators ATHERSYS, INC. (US) 2010-05-18 US disclosed
US-20060003990-A1 Substituted azepine derivatives as serotonin receptor modulators ATHERSYS, INC. 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060003990-A1 Substituted azepine derivatives as serotonin receptor modulators HTR5A, HTR4, HTR7 ALDH1A1 1011/4885MAPT 4268/4885KDM4E 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.